Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self
The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Abstract
Naturally arising CD25(+)CD4(+) regulatory T cells actively maintain immunological self-tolerance. Deficiency in or dysfunction of these cells can be a cause of autoimmune disease. A reduction in their number or function can also elicit tumor immunity, whereas their antigen-specific population expansion can establish transplantation tolerance. They are therefore a good target for designing ways to induce or abrogate immunological tolerance to self and non-self antigens.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Growing evidence has shown that Treg cells are recruited into the TME and behave as powerful immunosuppressors.61, 62”
From Reactive Oxygen Species in Cancer: Current Findings and Future Directions (2021) · cites this paper as [62]
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Self-citationFoxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745 · cited 1×
“In addition, they specifically express Foxp3 , which encodes a transcription factor, as a key control gene in their development and functio”
BackgroundPark, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Self-citationA CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Sakaguchi, S. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,306
Self-citationThe Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032 · cited 1×
“The fact that many tumor-associated antigens recognized by autologous T cells in cancer patients are antigenically normal self constituents indicates that natural CD25 + CD4 + T reg cells engaged in the maintenance of self-tolerance may concomitantly impede immunosurveillance against autologous tumor cell”
BackgroundTivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
Bach, J.-F. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020100 · Cited by 2,687 · cited 1×
“Furthermore, it is well documented that the incidence of autoimmune and other inflammatory diseases, including inflammatory bowel disease and allergy, has increased recently in developed countrie”
BackgroundThornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639 · cited 1×
“Furthermore, a CD28 signal to peripheral CD25 + CD4 + T reg cells, together with a TCR signal, attenuates suppression; for example, strong in vitro ligation of CD28 along with TCR stimulation abrogates the anergic and suppressive state of CD25 + CD4 + T reg cells, triggering their proliferatio”
BackgroundBrunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S.-A., Wilkinson, J. E., Galas, D., Ziegler, S. F., & Ramsdell, F. (2001) · Nature Genetics · doi:10.1038/83784 · Cited by 2,636
Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., & Sakaguchi, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.303 · Cited by 2,233
Self-citationRead, S., Malmström, V., & Powrie, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.295 · Cited by 2,205
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
Ueda, H., Howson, J. M. M., Esposito, L., Heward, J., Snook, Chamberlain, G., Rainbow, D. B., Hunter, K. M. D., Smith, A. N., Di Genova, G., et al. (2003) · Nature · doi:10.1038/nature01621 · Cited by 2,175
Salomon, B., Lenschow, D. J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., & Bluestone, J. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80195-8 · Cited by 2,081
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. (2003) · Science · doi:10.1126/science.1078231 · Cited by 1,997
Regulatory T Cell Clones Induced by Oral Tolerance: Suppression of Autoimmune Encephalomyelitis
Chen, Y., Kuchroo, V. K., Inobe, J.-I., Hafler, D. A., & Weiner, H. L. (1994) · Science · doi:10.1126/science.7520605 · Cited by 1,973 · cited 1×
“This high IL-2 dependency, in addition to Foxp3 expression, is an important feature of natural T reg cells that may differentiate them from other T cells and other types of T reg cells, such as IL-10- or TGF-β-dependent T reg cell”
BackgroundWildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance
Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y., & Sakaguchi, S. (2002) · Nature Immunology · doi:10.1038/ni759 · Cited by 1,729
Self-citationRegulatory T cells mediate maternal tolerance to the fetus
Aluvihare, V. R., Kallikourdis, M., & Betz, A. G. (2004) · Nature Immunology · doi:10.1038/ni1037 · Cited by 1,657 · cited 1×
“These in vivo and in vitro ways of inducing immunological tolerance to organ transplants could in principle be applied to re-establish self-tolerance in autoimmune disease, control aberrant or excessive immune responses to non-self antigens (immunopathology and allergy) and maintain feto-maternal tolerance in pregnanc”
BackgroundNakamura, K., Kitani, A., & Strober, W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.629 · Cited by 1,594
Phan, G. Q., Yang, J. C., Sherry, R. M., Hwu, P., Topalian, S. L., Schwartzentruber, D. J., Restifo, N. P., Haworth, L. R., Seipp, C. A., Freezer, L. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533209100 · Cited by 1,575 · cited 1×
“For example, administration of monoclonal antibody to CTLA-4 or to GITR, either of which can cause autoimmune disease in mice, is able to elicit effective tumor immunity by both attenuating T reg cell–mediated control of effector T cells and enhancing their effector activit”
BackgroundTakahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., Shimizu, J., & Sakaguchi, S. (1998) · International Immunology · doi:10.1093/intimm/10.12.1969 · Cited by 1,568
Self-citationShimizu, J., Yamazaki, S., & Sakaguchi, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5211 · Cited by 1,491
Self-citationCD4+CD25+ Immunoregulatory T Cells
McHugh, R. S., Whitters, M. J., Piccirillo, C. A., Young, D. A., Shevach, E. M., Collins, M., & Byrne, M. C. (2002) · Immunity · doi:10.1016/s1074-7613(02)00280-7 · Cited by 1,395
Modulation of tryptophan catabolism by regulatory T cells
Fallarino, F., Grohmann, U., Hwang, K. W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M. L., Fioretti, M. C., Alegre, M.-L., & Puccetti, P. (2003) · Nature Immunology · doi:10.1038/ni1003 · Cited by 1,374 · cited 1×
“CTLA-4 on T reg cells triggers induction of the enzyme indolamine 2, 3-dioxygenase by interacting with CD80 and/or CD86 on dendritic cells (DCs”
BackgroundAutoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.
Asano, M., Toda, M., Sakaguchi, N., & Sakaguchi, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.387 · Cited by 1,330 · cited 1×
“Such efforts have shown that the CD25 molecule, which is expressed by 5–10% of CD4 + T cells and 5% of CD4 + CD8 − mature thymocytes in normal naive mice, is able to operationally if not specifically differentiate naturally present autoimmune-preventive T reg cells from other T cell”
BackgroundSelf-citationRegulatory T cells in transplantation tolerance
Wood, K. J., & Sakaguchi, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri1027 · Cited by 1,317
Self-citationOnizuka, S., Tawara, I., Shimizu, J., Sakaguchi, S., Fujita, T., & Nakayama, E. (1999) · PubMed · Cited by 1,255
Self-citationRegulatory T Cells in Autoimmmunity
Shevach, E. M. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.423 · Cited by 1,236
Setoguchi, R., Hori, S., Takahashi, T., & Sakaguchi, S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041982 · Cited by 1,235
Self-citationIn Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes
Tang, Q., Henriksen, K. J., Bi, M., Finger, E. B., Szot, G., Ye, J., Masteller, E. L., McDevitt, H., Bonyhadi, M., & Bluestone, J. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040139 · Cited by 1,221 · cited 1×
“In a therapeutic context, there is accumulating evidence with animal models that natural CD25 + CD4 + T reg cell populations expanded in vivo or ex vivo can be used not only for preventing autoimmune disease but also for treating ongoing autoimmune responses by suppressing the population expansion and function of effe…”
BackgroundTumor Antigens Recognized by T Lymphocytes
Boon, T., Cerottini, J.-C., Van den Eynde, B., van der Bruggen, P., & Van Pel, A. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.002005 · Cited by 1,221
Itoh, M., Takahashi, T., Sakaguchi, N., Kuniyasu, Y., Shimizu, J., Otsuka, F., & Sakaguchi, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5317 · Cited by 1,211
Self-citationRegulatory T cells in the control of immune pathology
Maloy, K. J., & Powrie, F. (2001) · Nature Immunology · doi:10.1038/ni0901-816 · Cited by 1,175
Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment
Willerford, D. M., Chen, J., Ferry, J. A., Davidson, L., Ma, A., & Alt, F. W. (1995) · Immunity · doi:10.1016/1074-7613(95)90180-9 · Cited by 1,080
Sutmuller, R. P. M., van Duivenvoorde, L. M., van Elsas, A., Schumacher, T. N. M., Wildenberg, M. E., Allison, J. P., Toes, R. E. M., Offringa, R., & Melief, C. J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.823 · Cited by 1,008 · cited 1×
“This possibility seems to be the case, because depletion of CD25 + CD4 + T cells before tumor challenge elicits effective immune responses to syngeneic tumors in otherwise nonresponding mic”
BackgroundMechanisms of suppression by suppressor T cells
von Boehmer, H. (2005) · Nature Immunology · doi:10.1038/ni1180 · Cited by 1,007
Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by Lipopolysaccharide
Caramalho, I., Lopes-Carvalho, T., Ostler, D., Zelenay, S., Haury, M., & Demengeot, J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021633 · Cited by 970 · cited 1×
“In addition, natural CD25 + CD4 + T reg cells are reported to selectively express several members of the TLR family, such as TLR4 (ref”
BackgroundFontenot, J. D., & Rudensky, A. Y. (2005) · Nature Immunology · doi:10.1038/ni1179 · Cited by 950
Chatila, T. A., Blaeser, F., Ho, N., Lederman, H. M., Voulgaropoulos, C., Helms, C., & Bowcock, A. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11679 · Cited by 940
Deregulated T Cell Activation and Autoimmunity in Mice Lacking Interleukin-2 Receptor β
Suzuki, H., Kündig, T. M., Furlonger, C., Wakeham, A., Timms, E., Matsuyama, T., Schmits, R., Simard, J. J. L., Ohashi, P. S., Griesser, H., et al. (1995) · Science · doi:10.1126/science.7770771 · Cited by 871
Direct Expansion of Functional CD25+ CD4+ Regulatory T Cells by Antigen-processing Dendritic Cells
Yamazaki, S., Iyoda, T., Tarbell, K., Olson, K., Velinzon, K., Inaba, K., & Steinman, R. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030422 · Cited by 865
Suri-Payer, E., Amar, A. Z., Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1212 · Cited by 860
Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells
Yagi, H., Nomura, T., Nakamura, K., Yamazaki, S., Kitawaki, T., Hori, S., Maeda, M., Onodera, M., Uchiyama, T., Fujii, S., et al. (2004) · International Immunology · doi:10.1093/intimm/dxh165 · Cited by 801 · cited 1×
“Although these findings indicate CD25 is a 'rational' molecular marker for natural T reg cells, some T cells in the CD25 − CD45RB lo CD4 + T cell fraction, which represents less than 10% of CD25 − CD4 + T cells in normal naive mice, also have intermediate expression of Foxp3 and show in vitro regulatory activit”
BackgroundSelf-citationCD4 Regulatory T Cells Prevent Lethal Autoimmunity in IL-2Rβ-Deficient Mice
Malek, T. R., Yu, A., Vincek, V., Scibelli, P., & Kong, L. (2002) · Immunity · doi:10.1016/s1074-7613(02)00367-9 · Cited by 779
Tarbell, K. V., Yamazaki, S., Olson, K., Toy, P., & Steinman, R. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040180 · Cited by 738
Sakaguchi, S., Fukuma, K., Kuribayashi, K., & Masuda, T. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.1.72 · Cited by 729
Self-citationRecognition of the Peripheral Self by Naturally Arising CD25+ CD4+ T Cell Receptors
Hsieh, C.-S., Liang, Y., Tyznik, A. J., Self, S. G., Liggitt, D., & Rudensky, A. Y. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.009 · Cited by 719
The Interaction Properties of Costimulatory Molecules Revisited
Collins, A. V., Brodie, D. W., Gilbert, R. J. C., Iaboni, A., Manso-Sancho, R., Walse, B., Stuart, D. I., van der Merwe, P. A., & Davis, S. J. (2002) · Immunity · doi:10.1016/s1074-7613(02)00362-x · Cited by 684 · cited 1×
“Furthermore, the expression of CD80 or CD86 may differentially activate or deactivate T reg cells; for example, CD80 has much higher affinity for CTLA-4 than does CD86; similarly, CD86 has a higher affinity for CD28 than does CD80 (refs”
BackgroundCutting Edge: CD28 Controls Peripheral Homeostasis of CD4+CD25+ Regulatory T Cells
Tang, Q., Henriksen, K. J., Boden, E. K., Tooley, A. J., Ye, J., Subudhi, S. K., Zheng, X. X., Strom, T. B., & Bluestone, J. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3348 · Cited by 670
Interleukin 2 Signaling Is Required for CD4+ Regulatory T Cell Function
Furtado, G. C., de Lafaille, M. A. C., Kutchukhidze, N., & Lafaille, J. J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020190 · Cited by 625
Antigen-dependent Proliferation of CD4+ CD25+ Regulatory T Cells In Vivo
Walker, L. S. K., Chodos, A., Eggena, M., Dooms, H., & Abbas, A. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030315 · Cited by 588
Gambineri, E., Torgerson, T. R., & Ochs, H. D. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200307000-00010 · Cited by 575
Thornton, A. M., Donovan, E. E., Piccirillo, C. A., & Shevach, E. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6519 · Cited by 560
Continuous Activation of Autoreactive CD4+ CD25+ Regulatory T Cells in the Steady State
Fisson, S., Darrasse-Jèze, G., Litvinova, E., Septier, F., Klatzmann, D., Liblau, R., & Salomon, B. L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030686 · Cited by 522
Control of intestinal inflammation by regulatory T cells
Singh, B., Read, S., Asseman, C., Malmström, V., Mottet, C., Stephens, L. A., Stepankova, R., Tlaskalova, H., & Powrie, F. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820115.x · Cited by 500
Stephens, G. L., McHugh, R. S., Whitters, M. J., Young, D. A., Luxenberg, D., Carreno, B. M., Collins, M., & Shevach, E. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.5008 · Cited by 499
Large-scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cells
Hoffmann, P., Eder, R., Kunz-Schughart, L. A., Andreesen, R., & Edinger, M. (2004) · Blood · doi:10.1182/blood-2004-01-0086 · Cited by 494
Biology of the Interleukin-2 Receptor
Nelson, B. H., & Willerford, D. M. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60386-7 · Cited by 475
Almeida, A. R. M., Legrand, N., Papiernik, M., & Freitas, A. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4850 · Cited by 468
Munn, D. H., Sharma, M. D., & Mellor, A. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4100 · Cited by 457
Peng, Y., Laouar, Y., Li, M. O., Green, E. A., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400810101 · Cited by 416
Powrie, F., & Mason, D. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.6.1701 · Cited by 413
Huber, S., Schramm, C., Lehr, H. A., Mann, A., Schmitt, S., Becker, C., Protschka, M., Galle, P. R., Neurath, M. F., & Blessing, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6526 · Cited by 390
Toll-Dependent Control Mechanisms of CD4 T Cell Activation
Pasare, C., & Medzhitov, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.10.006 · Cited by 386
Distinct roles of CTLA‐4 and TGF‐β in CD4+CD25+ regulatory T cell function
Tang, Q., Boden, E. K., Henriksen, K. J., Bour‐Jordan, H., Bi, M., & Bluestone, J. A. (2004) · European Journal of Immunology · doi:10.1002/eji.200425143 · Cited by 377
Autoreactive T Cells in Healthy Individuals
Danke, N. A., Koelle, D. M., Yee, C., Beheray, S., & Kwok, W. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.5967 · Cited by 377
In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro
Klein, L., Khazaie, K., & von Boehmer, H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533365100 · Cited by 375 · cited 1×
“Moreover, they undergo antigen-specific proliferation in vivo after strong antigenic stimulation or in vitro stimulation with antigen and high-dose IL-2, although to a lesser degree than the proliferation of effector T cell”
BackgroundMouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells
Tone, M., Tone, Y., Adams, E., Yates, S. F., Frewin, M. R., Cobbold, S. P., & Waldmann, H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2334901100 · Cited by 345
Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease
Paust, S., Lu, L., McCarty, N., & Cantor, H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403342101 · Cited by 328
McHugh, R. S., & Shevach, E. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.5979 · Cited by 319
Stephens, L. A., & Mason, D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3105 · Cited by 311
CD40 Ligation Releases Immature Dendritic Cells from the Control of Regulatory CD4+CD25+ T Cells
Serra, P., Amrani, A., Yamanouchi, J., Han, B., Thiessen, S., Utsugi, T., Verdaguer, J., & Santamaria, P. (2003) · Immunity · doi:10.1016/s1074-7613(03)00327-3 · Cited by 291 · cited 1×
“The number of CD25 + CD4 + CD8 − thymocytes and T cells is substantially reduced in CD40-deficient mice and to a lesser degree in CD40 ligand–deficient mic”
BackgroundKanamaru, F., Youngnak, P., Hashiguchi, M., Nishioka, T., Takahashi, T., Sakaguchi, S., Ishikawa, I., & Azuma, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7306 · Cited by 285
Self-citationGolgher, D., Jones, E., Powrie, F., Elliott, T., & Gallimore, A. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200211)32:11<3267::aid-immu3267>3.0.co;2-1 · Cited by 282
CD86 and CD80 Differentially Modulate the Suppressive Function of Human Regulatory T Cells
Zheng, Y., Manzotti, C. N., Liu, M., Burke, F., Mead, K. I., & Sansom, D. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2778 · Cited by 279
Godfrey, W. R., Ge, Y. G., Spoden, D. J., Levine, B. L., June, C. H., Blazar, B. R., & Porter, S. B. (2004) · Blood · doi:10.1182/blood-2004-01-0151 · Cited by 277
Cutting Edge: Lymphoproliferative Disease in the Absence of CTLA-4 Is Not T Cell Autonomous
Bachmann, M. F., Köhler, G., Ecabert, B., Mak, T. W., & Kopf, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1128 · Cited by 235 · cited 1×
“Furthermore, a lethal lymphoproliferative and autoimmune syndrome that spontaneously develops in CTLA-4-deficient mice is not T cell autonomous but can be inhibited by wild-type T cell”
BackgroundCD25+CD4+ T cells contribute to the control of memory CD8+ T cells
Murakami, M., Sakamoto, A., Bender, J., Kappler, J., & Marrack, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132254399 · Cited by 234 · cited 1×
“Furthermore, administration of neutralizing monoclonal antibody to IL-2 to normal naive mice selectively reduces the number of CD25 + CD4 + T cells in the thymus and peripher”
BackgroundNishimura, E., Sakihama, T., Setoguchi, R., Tanaka, K., & Sakaguchi, S. (2004) · International Immunology · doi:10.1093/intimm/dxh122 · Cited by 233 · cited 1×
“Although these findings indicate CD25 is a 'rational' molecular marker for natural T reg cells, some T cells in the CD25 − CD45RB lo CD4 + T cell fraction, which represents less than 10% of CD25 − CD4 + T cells in normal naive mice, also have intermediate expression of Foxp3 and show in vitro regulatory activit”
BackgroundSelf-citationControl of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells
Fehervari, Z. (2004) · International Immunology · doi:10.1093/intimm/dxh178 · Cited by 221 · cited 1×
“Correspondingly, antigen-presenting mature CD86 hi DCs trigger T reg cell proliferation, indicating that activated DCs not only activate naive T cells but also attenuate T reg cell–mediated suppression, thus synergistically provoking effective immune responses to microbe”
BackgroundJi, H.-B., Liao, G., Faubion, W. A., Abadía-Molina, A. C., Cozzo, C., Laroux, F. S., Caton, A., & Terhorst, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.5823 · Cited by 198
THOMPSON, C. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.05.001 · Cited by 193
Reddy, J., Illes, Z., Zhang, X., Encinas, J., Pyrdol, J., Nicholson, L., Sobel, R. A., Wucherpfennig, K. W., & Kuchroo, V. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404444101 · Cited by 187
Kumanogoh, A., Wang, X., Lee, I., Watanabe, C., Kamanaka, M., Shi, W., Yoshida, K., Sato, T., Habu, S., Itoh, M., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.353 · Cited by 175
Self-citationWolf, M., Schimpl, A., & Hünig, T. (2001) · European Journal of Immunology · Cited by 175
Regulatory T cells and organ transplantation
Waldmann, H. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2003.12.007 · Cited by 173 · cited 1×
“Certain monoclonal antibodies or drugs whose administration for a limited period can induce long-term T reg cell–dependent graft tolerance may have this effect as a common mechanism of tolerance inductio”
BackgroundNishikawa, H., Kato, T., Tanida, K., Hiasa, A., Tawara, I., Ikeda, H., Ikarashi, Y., Wakasugi, H., Kronenberg, M., Nakayama, T., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834479100 · Cited by 168
Suppressor T Cells in Human Diseases
Baecher-Allan, C., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040812 · Cited by 167 · cited 1×
“Recent years, however, have witnessed resurgent interest in suppressor or regulatory T cells (T reg cells) in many fields of basic and clinical immunolog”
BackgroundRole of GITR in activation response of T lymphocytes
Ronchetti, S., Nocentini, G., Riccardi, C., & Pandolfi, P. P. (2002) · Blood · doi:10.1182/blood-2001-12-0276 · Cited by 165 · cited 1×
“Although GITR-deficient mice are reportedly normal, administration of agonistic monoclonal antibody to GITR to normal mice elicits autoimmune diseases similar to that produced by T reg cell depletio”
ResultDiabetes Mellitus and Autoimmunity in Patients with the Congenital Rubella Syndrome
Ginsberg‐Fellner, F., Witt, M. E., Fedun, B., Taub, F. E., Dobersen, M. J., McEvoy, R. C., Cooper, L. Z., Notkins, A. L., & Rubinstein, P. (1985) · Clinical Infectious Diseases · doi:10.1093/clinids/7.supplement_1.s170 · Cited by 157
Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells
Bour-Jordan, H., Salomon, B. L., Thompson, H. L., Szot, G. L., Bernhard, M. R., & Bluestone, J. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420483 · Cited by 157 · cited 1×
“The number of CD25 + CD4 + CD8 − thymocytes and T cells is substantially reduced in CD40-deficient mice and to a lesser degree in CD40 ligand–deficient mic”
BackgroundKrämer, S., Schimpl, A., & Hünig, T. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.1769 · Cited by 144
Interleukin‐2 Deficient Mice: A New Model to Study Autoimmunity and Self‐Tolerance
Horak, I. D., Löhler, J., Ma, A. I., & Smith, K. A. (1995) · Immunological Reviews · doi:10.1111/j.1600-065x.1995.tb00092.x · Cited by 142
Manzotti, C. N., Tipping, H., Perry, L. C. A., Mead, K. I., Blair, P. J., Zheng, Y., & Sansom, D. M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(2002010)32:10<2888::aid-immu2888>3.0.co;2-f · Cited by 139
QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing Il2
Encinas, J. A., Wicker, L. S., Peterson, L. B., Mukasa, A., Teuscher, C., Sobel, R. A., Weiner, H. L., Seidman, C. E., Seidman, J. G., & Kuchroo, V. K. (1999) · Nature Genetics · doi:10.1038/5941 · Cited by 131
Taguchi, O., & Takahashi, T. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260730 · Cited by 97
X-chromosome inactivation analysis in a female carrier of FOXP3 mutation
TOMMASINI, A., FERRARI, S., MORATTO, D., BADOLATO, R., BONIOTTO, M., PIRULLI, D., NOTARANGELO, L. D., & ANDOLINA, M. (2002) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2002.01940.x · Cited by 93
Adoptive transfer of autoimmune diabetes and thyroiditis to athymic rats.
McKeever, U., Mordes, J. P., Greiner, D. L., APPEL, M. C., Rozing, J., Handler, E. S., & Rossini, A. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7618 · Cited by 85
Rolph, M. S., Raupach, B., Köbernick, H. H. C., Collins, H. L., Pérarnau, B., Lemonnier, F. A., & Kaufmann, S. H. E. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200106)31:6<1944::aid-immu1944>3.0.co;2-r · Cited by 84
CD4 + CD25 + T-Cell Production in Healthy Humans and in Patients with Thymic Hypoplasia
Sullivan, K. E., McDonald-McGinn, D., & Zackai, E. H. (2002) · Clinical and Vaccine Immunology · doi:10.1128/cdli.9.5.1129-1131.2002 · Cited by 82
Coutinho, A., Hori, S., Carvalho, T., Caramalho, I., & Demengeot, J. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820107.x · Cited by 74 · cited 1×
“There is also substantial evidence that T cell–mediated active suppression of self-reactive T cells is another essential mechanism of self-toleranc”
BackgroundInterleukin-2 Is Indispensable for Development of Immunological Self-Tolerance
Klebb, G., Autenrieth, I. B., Haber, H., Gillert, E., Sadlack, B., Smith, K. A., & Horak, I. D. (1996) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1996.0190 · Cited by 73 · cited 1×
“Notably, the number of CD25 + CD4 + T cells is selectively reduced in the thymus and periphery of IL-2-deficient mice, regardless of the normal number, subset composition and function of other CD4 + and CD8 + T cell”
BackgroundPodolin, P. L., Wilusz, M. B., Cubbon, R. M., Pajvani, U. B., Lord, C. J., Todd, J. A., Peterson, L. B., Wicker, L. S., & Lyons, P. (2000) · Cytokine · doi:10.1006/cyto.1999.0609 · Cited by 71
Chastagner, P., Moreau, J., Jacques, Y., Tanaka, T. T., Miyasaka, M., Kondo, M., Sugamura, K., & Thèze, J. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260131 · Cited by 30 · cited 1×
“CD25 is therefore indispensable for natural T reg cells as a component of the high-affinity IL-2R, because mouse IL-2R requires all three receptor chains (α, β and γ) for IL-2 binding, in contrast to human IL-2R, for which β- and γ-chains can also form an intermediate-affinity receptor for IL-2 (refs”
BackgroundChano, F., & Descoteaux, A. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(2002010)32:10<2800::aid-immu2800>3.0.co;2-5 · Cited by 10
Research works printed but not linked: 1
- Setoguchi, R., Hori, S., Takahashi, T. & Sakaguchi, S. A crucial role of IL-2 in the homeostatic maintenance of CD25+CD4+ regulatory T cells: induction of autoimmune disease by neutralization of IL-2. J. Exp. Med. (in the press).
Cited by
Regulatory T Cells and Immune Tolerance
Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,325
“Conversely, CD25 + CD4 + T cells enriched from normal mice suppress allergy, establish tolerance to organ grafts, prevent graft-versus-host disease after bone marrow transplantation , and promote feto-maternal tolerance (reviewed in Sakaguchi, 2005) (Figure 1A).”
BackgroundSelf-citationImmunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
“Per se, Tregs are hyporesponsive to T-cell receptor (TCR) stimulation in vitro, but high amounts of IL-2 or stimuli bypassing the TCR can overcome their anergic state (224).”
BackgroundVeldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Gleeson, M., Bishop, N. C., Stensel, D. J., Lindley, M. R., Mastana, S. S., & Nimmo, M. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3041 · Cited by 2,470
“CD4 + CD25 + T Reg cells specifically express the transcription factor forkhead box P3 (FOXP3”
BackgroundIL-10: The Master Regulator of Immunity to Infection
Couper, K. N., Blount, D. G., & Riley, E. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.5771 · Cited by 2,223
Metadata
- Authors
- Sakaguchi, S.
- Affiliations
- Kyoto University (JP)
- Corresponding author
- Sakaguchi, Shimon
- ORCID
- Sakaguchi, Shimon
- Venue
- Nature Immunology
- Published
- 2005-03-22
- Volume
- 6
- Issue
- 4
- Pages
- 345-352
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2004708987
- Cited by
- 2,669
- References
- 109
- Citations by year
- 2026: 12 · 2025: 33 · 2024: 39 · 2023: 54 · 2022: 59 · 2021: 68 · 2020: 68 · 2019: 84 · 2018: 83 · 2017: 92 · 2016: 98 · 2015: 113 · 2014: 127 · 2013: 148 · 2012: 169
- FWCI
- 22.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- Foxp3, regulatory T cells, CD4+CD25+ T cells, immune tolerance, self-tolerance, autoimmune disease, antitumor immunity, transplantation tolerance, antigen-specific T cell expansion, immunomodulation
- MeSH terms
- Animals, Antigens, Differentiation, Autoimmune Diseases, DNA-Binding Proteins, Humans, Lymphocyte Activation, Neoplasms, T-Lymphocytes, Thymus Gland, Transplantation Immunology, Receptors, Interleukin-2, Antigens, CD, CD4 Antigens, Self Tolerance, Forkhead Transcription Factors, CTLA-4 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.